Kefzero

Cefuroxime Axetil, the active ingredient in Kefzero, is a second‑generation cephalosporin presented as an oral tablet for oral use. It treats bacterial infections such as respiratory, urinary, and skin infections in adults and children as directed by a healthcare professional.

GNH USA supplies Kefzero as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and health‑care institutions worldwide through regulated distribution channels, ensuring product quality and compliance with local regulations. Our network enables reliable access to essential antibiotics across diverse markets.

Cefuroxime Axetil is a second‑generation cephalosporin used to treat bacterial infections in various organ systems. - Respiratory tract infections: effective against community‑acquired pneumonia and acute bronchitis. - Urinary tract infections: active against common uropathogens causing cystitis and pyelonephritis. - Skin and soft tissue infections: treats cellulitis, abscesses and wound infections. - Sinusitis: reduces bacterial load in acute bacterial sinusitis. - Otitis media: clears infection in middle‑ear inflammation.

Cefuroxime Axetil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Headache: transient mild headache. - Rash: erythematous skin eruption. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Clostridioides difficile colitis: severe diarrhea with possible colitis. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane involvement. - Hematologic abnormalities: neutropenia or thrombocytopenia. - Hepatic enzyme elevation: abnormal liver function tests. - Renal impairment: worsening kidney function in susceptible patients.

When prescribing Cefuroxime Axetil, consider the following precautions to ensure safe use. - Renal function: adjust dose in patients with impaired renal clearance. - Allergy history: avoid in individuals with known hypersensitivity to cephalosporins or penicillins. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Anticoagulants: monitor INR or PT when co‑administered with warfarin. - Pediatric dosing: calculate dose based on body weight and age. - Store at ambient temperature: keep in the original container, protect from moisture and excessive heat.

Cefuroxime Axetil can interact with other medicines; monitor the following interactions.

Major Interactions (Avoid): - Probenecid: may increase serum cefuroxime concentrations, raising toxicity risk. - Warfarin: can potentiate anticoagulant effect, requiring close INR monitoring. - Live vaccines: concurrent use may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal excretion, necessitating dose adjustment. - Aminoglycosides: combined nephrotoxic potential warrants renal function monitoring. - Oral contraceptives: cefuroxime may reduce hormonal efficacy, advise additional contraceptive measures.